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abstract 
Routinely collected data are a powerful research resource and offer the opportunity to further our 
understanding of epilepsy mortality and Sudden Unexpected Death in Epilepsy (SUDEP). The 
advantages of using routinely collected data include that it often covers whole populations, is 
al ead  olle ted, a d a  e easil  li ked to othe  data sou es. A sig ifi a t disad a tage is the 
diffi ult  i  o tai i g a u ate auses of death a d o e tl  ide tifying cases of SUDEP. Using and 
linking data from epilepsy death registries can improve the quality of mortality data for research. 
Epilepsy prevalence, incidence, and mortality rates are associated with socioeconomic deprivation. 
Further research into understanding the link between deprivation and epilepsy mortality could lead 
to ways to reduce epilepsy mortality. 
 
1. Introduction 
One of the many challenges faced in epilepsy mortality research is the accurate collection of 
information on the frequency and nature of deaths in order to understand causation and factors 
i flue i g o tality. Such data can be used in the surveillance of mortality and in other research 
themes such as in links to issues such as health inequalities. An excellent example of the value of 
surveillance has come from the various registers of pregnancy in epilepsy which have highlighted the 
risk from sodium valproate to the unborn child and led to major changes in clinical practice [1]. 
In this article, we discuss the value of routinely collected data and registries, focusing on their value 
i  esea h a d spe ifi all  i to the li k et ee  o talit  a d dep i atio . 
2. Routinely collected data 
Vast amounts of routinely collected electronic health, social, and personal data are generated 
throughout the world. These data can be anonymized, linked electronically, and used as a powerful 
healthcare research tool (data linkage). The ability to analyze routinely collected data depends 
critically on a secure anonymization pro ess, gi e  that spe ifi  i di idual o se t fo  esea h has 
not normally been obtained. Several technological and procedural systems have been established to 
ensure that linked data can be securely anonymized [2]. An example, which is used at the Secure 
A o ised I fo atio  Li kage data a k SAIL  at S a sea U i e sit  is the split file app oa h, 
he e patie t ide tifia le i fo atio  is sepa ated f o  the e ai de  of the data a d sepa atel  
encrypted [3]. 
There are several advantages of using routinely collected healthcare data for research when 
compared to other methods. The data have al-ready been collected and do not depend on recruiting 
i di iduals to spe ifi  t ials, hi h a  e ostl  a d a  i t odu e e uit e t ias. Routi el  
collected data are also relatively easily available on a population level. Retrospective cohort studies 
can be conducted with the above advantages which are a potentially powerful tool to study 
mortality in epilepsy and SUDEP. 
2.1. Issues when using routinely collected data for epilepsy mortality research 
Using routinely collected data to study epilepsy mortality and SUDEP relies on accurately identifying 
people with epilepsy. Hospital epilepsy registries or clinical neurology databases often contain 
reliable epilepsy diagnosis from specialists. However, these registries do not often cover the 
complete relevant epilepsy population and cannot always easily be used in conjunction with other 
data. Primary care and hospital epilepsy diagnosis codes are therefore used more frequently to 
identify people with epilepsy. There are concerns that primary care and hospital epilepsy diagnoses 
are not always accurately routinely coded, e.g., acute symptomatic seizures, convulsive syncope, or 
dissociative seizures being coded as epilepsy. 
Codi g s ste s do a  sig ifi a tl  f o  ou t  to ou t , a d so eti es, the e a e sig ifi a t 
differences in healthcare systems within individual countries which are important to consider when 
usi g disease odes fo  esea h. Se e al fa to s a  i flue e the a uracy of epilepsy diagnosis 
codes such as who enters the codes (clinicians versus administrators) or incentives to maintain 
accurate disease statistics [4]. Generally though, disease diagnosis and management codes seem to 
be reasonably reliable in ascertaining people with epilepsy in routinely collected data, especially 
when combined with other epilepsy information such as regular prescription of anti-epileptic drugs 
(AEDs) or electroencephalographic (EEG) results (where available). For example, Australian, Italian, 
American, and UK studies achieved sensitivities of 82– % a d spe ifi ities of –100% when 
identifying people with epilepsy from routinely collected data [5–8]. 
The vast majority of deaths will be captured by legal frameworks in ol i g death e tifi ates o  
equivalent systems which are generally accessible for most routinely collected research systems. 
They will accurately capture deaths ut the e a e justified o e s a out the a curacy of recorded 
auses of deaths. Fo  e a ple, i  a p e ious stud , % of death e tifi ates i  E gla d a d Wales 
had an inaccurate cause of death when reviewed by medical examiners [9]. 
There are even o e o e s a out the a u ate e o di g of SUDEP o  death e tifi atio . A  
expert chart review found that 5.3%of 399 American out of hospital sudden deaths were SUDEP but 
seizures or complications of seizures were only recorded as the primary cause of 
deathinaround20%of these cases [10]. A retrospective evaluation of forensic autopsy cases in 
Maryland, USA found 74 cases of SUDEP but SUDEP was listed as the primary cause of death in only 
8 cases [11].A UK national audit of epilepsy-related death found that the cause of death was 
considered to be inadequately stated in 41% cases of post-mortem reports [12]. 
A othe  issue to o side  he  a al zi g death e tifi ate data is the li itatio  of so e odi g 
s ste s used i  death e tifi atio . The I te atio al Statisti al Classifi atio  of Diseases a d 
Related Health P o le s ICD  is a o o l  used s ste  fo  death e tifi atio . SUDEP has o l  
been incorporated in the very latest version (ICD-11) released in 2018; all other versions, which are 
still commonly used, do not contain a code for SUDEP [13,14]. 
3. Registries of epilepsy deaths 
Disease-based registries can play a vital role in surveillance in medicine, e.g., the UK epilepsy and 
pregnancy registry [15], and MBRRACE-UK: Mothers and Babies: Reducing Risk through Audits and 
Co fide tial E ui ies a oss the UK [ ]. Epileps  death egist ies a  aug e t populatio  le el 
data with spe ifi  o talit  data a d idge the gap aused  the li itatio s i  the a u a  of 
recording epilepsy deaths as described above. Epilepsy death registries offer: opportunities to ac-
curately capture epilepsy-related deaths, a rich set of valuable data and information from relatives 
and clinicians, and support to the bereaved contributing sensitive information. To the best of our 
k o ledge, the e a e fi e epileps  death egiste s; these a e su a ized in Table 1 and described 
below. 
The Epilepsy Deaths Register (EDR) is owned and managed by the UK-based charity SUDEP Action 
and is described in detail in the linked article in this issue by Osland and Thomas [17]. Individuals 
from all over the world can register epilepsy deaths in the EDR, but most of its 750 entries are 
currently from the UK and Ireland. Bereaved relatives complete information (with appropriate 
support) relating to the cir u sta es of the death hi h a  e li ked to death e tifi ates. 
The EDR for Ireland, setup with a partnership between the charities Epilepsy Ireland and SUDEP 
Action, allows friends or relatives to register epilepsy deaths [18]. This register is based on the UK 
EDR. 
The North American SUDEP Registry (NASR) was launched in 2011 [19,20]. Family members of 
people with epilepsy who have had an un-expected death can register their relatives' death with 
NASR. Family members can be referred to NASR from a variety of sources including clinicians, 
coroners, or advocacy groups [21]. They then complete a phone interview and are asked to allow 
NASR permission to view medical records. The North American SUDEP Registry collects tissue 
sa ples he  app op iate a d also e olls li i g fi st deg ee elati es a d o trol decedents. 
Verducci et al. recently analyzed NASR data, highlighting the utility of SUDEP registries [21]. As of 
June2018 ,there e e NASR pa ti ipa ts ith  defi ite a d p o a le ases of SUDEP [ ].Of 
these 237 cases, 40% had generalized epilepsy and 60% had focal epilepsy; 11% were not prescribed 
antiepileptic medications (AEDs) and 37% of those prescribed AEDs had reportedly missed their last 
medication dose. As similar studies have shown, there was a low rate of SUDEP awareness with only 
16% of next of kin being aware of SUDEP. Although the data highlighted clinical features that are 
known to be associated with SUDEP risk (e.g., young age and frequent generalized tonic-clonic 
seizures [GTCS]), there were a minority of cases with relatively benign epilepsies (3 cases with 
childhood epilepsy with centrotemporal spikes and 7 cases who had never had a GTCS before 
SUDEP) [21]. 
The French network, Réseau Sentinelle Mortalité Epilepsie (RSME), was established in 2010. The 
network includes approximately 120 practitioners including neurologists, epileptologists, and 
pediatric neurologists from each region of France. The RSME also includes a national network of 
bereaved families. Epilepsy deaths are reported by physicians or bereaved families [22]. From 
January 2010 to October 2018, 275 deaths were recorded. The causes of death were as follows: 
78%SUDEP (N = 207), 6% accidental trauma, 5% drowning, 5% status epilepticus, 2% suicide, and 6% 
other causes. 
The Canadian Pediatric SUDEP Registry (CPSR) was developed through collaboration with the 
Canadian Pediatric Epilepsy Network and the Canadian Pediatric Surveillance Program [23]. Monthly 
requests are sent to Canadian pediatricians to report pediatric SUDEP cases. After obtaining consent, 
data are collected in a similar format to the NASR to enable data sharing. 
Table 1 
A summary of the main epilepsy death registers. 
 
4. Examples of studies using population data 
Fazel et al. used routinely collected Swedish data to retrospectively study premature mortality in 
people with epilepsy and the role of psychiatric comorbidity [24]. The adjusted odds ratio of 
premature mortal-ity in the 69,995 people with epilepsy was 11.1 when compared with general 
population controls and 11.4 when compared with unaffected siblings. Fifteen percent of the deaths 
were from external causes with 75% of these individuals having a psychiatric comorbidity. 
One approach to account for the inaccurate coding of SUDEP is to re-view the medical notes of 
possible ases of SUDEP ide tified i  outi el  olle ted data. This is ot al a s possi le e ause of 
the ethical implications of reidentifying individuals from anonymized routinely collected data but is 
possible in some healthcare systems. 
For example, Sveinsson et al. ide tified  deaths i  ,  people ith epileps  i  S ede  i  
 usi g the atio al patie t egiste  a d li ked death e tifi ates [ ]. All death e tifi ates e e 
screened to identify possible cases of SUDEP, and then a detailed review of medical records was 
pe fo ed to ide tif  defi ite, p o a le, a d possi le ases of SUDEP. The  fou d a  i ide e of 
. /  patie t ea s of defi ite o  p o a le SUDEP. The  also fou d that epileps  as e tio ed 
o  the death e tifi ate i  o l  % of ases. 
The same authors used a similar method to analyze SUDEP risk in a population cohort over time. 
They found that the incidence of SUDEP in their population-based cohort decreased by around 7% 
per year in a six year follow-up period [26]. 
An American group demonstrated how registry data can augment population level data to identify 
cases of SUDEP. Ryvlin et al. studied SUDEP rates in a cohort of 40,443 patients who had vagus nerve 
stimulator (VNS) implants in the USA between 1988 and 2012 [27]. They used VNS manufacturer 
registry data about deaths in the cohort together with national cause of death data and an expert 
panel review process to identify SUDEP cases. There were 632 cases of SUDEP, and similarly to the 
Swedish study [26], they found that the rate of SUDEP decreased with follow-up time from 
. /  patie t ea s i  the fi st t o ea s after VNS implantation to 1.68/1000 patient years 
three to ten years after VNS implantation. Because of the limitations of this study, the cause of this 
fi di g is not known and could be caused by several factors including the natural long-term dynamic 
of SUDEP rate, attrition, and the impact of VNS therapy [27]. 
Where it is not possible to identify or reidentify individuals from population data in order to 
accuratel  o fi  auses of death o  SUDEP, the  usi g epileps  death egist ies ith a u ate 
auses of death ight offe  a  alte ati e. Regist ies o tai i g lists of defi ite ases of SUDEP o  
other epilepsy deaths can be linked (or anonymously linked if necessary) to population data; for 
e a ple, usi g a split file approach as used in the SAIL databank [3]. 
5. Deprivation 
Dep i atio  a  e defi ed as the la k of oppo tu ities a d e-sources which we might expect in 
society [28]. Deprivation is most accurately measured on an individual basis, e.g., individual income, 
housing, and access to resources. When this is not possible, then area-based measures of 
deprivation can be used. Measures of deprivation used in the UK include the Index of Multiple 
Deprivation (England) and the Welsh Index of Multiple Deprivation (Wales) [28,29]. These in-dices of 
deprivation calculate a deprivation score for a small geographical area (about 1500 people) based on 
weighted scores from eight domains. These domains represent different types of deprivation 
in ludi g i o e u e plo e t e efit lai a t ate , geog aphi al a ess to se i es p o i it  
to primary care and schools), and health (death rate, cancer rates). 
There is an established link between socioeconomic deprivation and epilepsy. Both epilepsy 
prevalence and incidence are positively correlated with increasing deprivation [30–32](Fig. 1). This 
suggests that factors associated with deprivation may cause epilepsy (social causation) as opposed 
to epilepsy itself causing deprivation (social drift) [33] . 
 
 
A recent report by Public Health England, covered in more detail elsewhere in this special edition, 
found that epilepsy-associated deaths in the most deprived areas are nearly three times more likely 
than in the least deprived areas [34,35]. This association was not found with other major 
neurological conditions but may be due to the fact that epilepsy prevalence is increased in areas of 
increased deprivation – if there are more people with epilepsy then there will be more deaths 
associated with epilepsy. Another possibility is that factors associated with deprivation cause 
increased mortality. For example, access to healthcare ser-vices is one measure used in indices of 
multiple deprivation [28,29]. Poorer access to healthcare services may mean that more deprived 
people with epilepsy do not have access to the same support that they re-quire for their epilepsy 
which may impact on mortality and SUDEP rates. 
Future research is needed to try and understand the reasons for this link between deprivation, 
epilepsy, and mortality. It may be that potentially reversible factors associated with deprivation are 
associated with epilepsy mortality as well offering the real opportunity to save lives. 
6. Conclusion 
The use of routinely collected data has the potential to provide a powerful tool to explore 
population- ased i flue es o  epileps  o tality. This approach will complement the increasingly 
rich data from registries. Future projects linking registry-ide tified data ith outi e datasets 
promise to improve the quality of routinely collected epilepsy mortality data. 
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